277 related articles for article (PubMed ID: 18043976)
1. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin.
Chandrakumaran K; Carr NJ; Mohamed F; Cecil TD; Moran BJ
JAMA Surg; 2023 May; 158(5):522-530. PubMed ID: 36920381
[TBL] [Abstract][Full Text] [Related]
3. Analysis of causes and prognostic impact of tube occlusion during hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei.
Liu Q; Jiao J; Li C; Chen Y; Wang B; Shi J; Yu G
World J Surg Oncol; 2024 May; 22(1):134. PubMed ID: 38769546
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Waikato, Aotearoa New Zealand: a 12-year experience.
Qin RX; Lim JH; Ly J; Fischer J; Smith N; Karalus M; Wu L; van Dalen R; Lolohea S
ANZ J Surg; 2024 Apr; 94(4):621-627. PubMed ID: 37994292
[TBL] [Abstract][Full Text] [Related]
5. Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Blackham AU; Swett K; Eng C; Sirintrapun J; Bergman S; Geisinger KR; Votanopoulos K; Stewart JH; Shen P; Levine EA
J Surg Oncol; 2014 Jun; 109(7):740-5. PubMed ID: 24375188
[TBL] [Abstract][Full Text] [Related]
6. A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.
Farquharson AL; Pranesh N; Witham G; Swindell R; Taylor MB; Renehan AG; Rout S; Wilson MS; O'Dwyer ST; Saunders MP
Br J Cancer; 2008 Aug; 99(4):591-6. PubMed ID: 18682713
[TBL] [Abstract][Full Text] [Related]
7. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study.
Trecourt A; Bakrin N; Glehen O; Gertych W; Villeneuve L; Isaac S; Benzerdjeb N; Fontaine J; Genestie C; Dartigues P; Leroux A; Quenet F; Marchal F; Odin C; Khellaf L; Svrcek M; Thierry S; Augros M; Omar A; Devouassoux-Shisheboran M; Kepenekian V;
Ann Surg Oncol; 2024 May; 31(5):3325-3338. PubMed ID: 38341381
[TBL] [Abstract][Full Text] [Related]
8. Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.
Ghelardi F; Raimondi A; Morano F; Randon G; Pannone A; Guaglio M; Mazzoli G; Nasca V; Milione M; Leoncini G; Sabella G; Greco GF; Lampis BR; Galassi M; Delfanti S; Nannini M; Intini R; Baratti D; Di Bartolomeo M; Deraco M; Pietrantonio F
Clin Colorectal Cancer; 2023 Dec; 22(4):450-456.e1. PubMed ID: 37657955
[TBL] [Abstract][Full Text] [Related]
9. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients.
Esquivel J; Sugarbaker PH
Ann Surg; 2001 Aug; 234(2):198-205. PubMed ID: 11505065
[TBL] [Abstract][Full Text] [Related]
10. Incidental Diagnosis of Pseudomyxoma Peritonei After Emergent Splenectomy.
Ferre AC; Burstein M; El-Hayek KM
Am Surg; 2023 Apr; 89(4):1115-1117. PubMed ID: 33342260
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiles of high-grade and low-grade pseudomyxoma peritonei.
Noguchi R; Yano H; Gohda Y; Suda R; Igari T; Ohta Y; Yamashita N; Yamaguchi K; Terakado Y; Ikenoue T; Furukawa Y
Cancer Med; 2015 Dec; 4(12):1809-16. PubMed ID: 26475379
[TBL] [Abstract][Full Text] [Related]
12. Transhepatic Bromelain and Acetylcysteine for Treatment of Posterior Gastric Pseudomyxoma Peritonei: A Case Report.
Sun SL; Sarofim M; Morris DL
Anticancer Res; 2024 May; 44(5):2239-2241. PubMed ID: 38677761
[TBL] [Abstract][Full Text] [Related]
13. Pathology of Mucinous Appendiceal Tumors and Pseudomyxoma Peritonei.
Ramaswamy V
Indian J Surg Oncol; 2016 Jun; 7(2):258-67. PubMed ID: 27065718
[TBL] [Abstract][Full Text] [Related]
14. Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy.
Haase E; Yoo D; Sugarbaker PH
World J Surg Oncol; 2009 May; 7():48. PubMed ID: 19454019
[TBL] [Abstract][Full Text] [Related]
15. A nomogram prediction model of pseudomyxoma peritonei established based on new prognostic factors of HE stained pathological images analysis.
Ma R; Su YD; Yan FC; Lin YL; Gao Y; Li Y
Cancer Med; 2024 Mar; 13(6):e7101. PubMed ID: 38506243
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery and perioperative intraperitoneal chemotherapy: a new standard of care for appendiceal mucinous tumors with peritoneal dissemination.
Sugarbaker PH
Clin Colon Rectal Surg; 2005 Aug; 18(3):204-14. PubMed ID: 20011303
[TBL] [Abstract][Full Text] [Related]
17. Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade.
Grotz TE; Royal RE; Mansfield PF; Overman MJ; Mann GN; Robinson KA; Beaty KA; Rafeeq S; Matamoros A; Taggart MW; Fournier KF
World J Gastrointest Oncol; 2017 Sep; 9(9):354-362. PubMed ID: 28979717
[TBL] [Abstract][Full Text] [Related]
18. Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei.
Romero-Ruiz A; Granados-Rodríguez M; Bura FI; Valenzuela-Molina F; Rufián-Andújar B; Martínez-López A; Rodríguez-Ortiz L; Ortega-Salas R; Torres-Martínez M; Moreno-Serrano A; Castaño J; Michán C; Alhama J; Vázquez-Borrego MC; Arjona-Sánchez Á
Biol Proced Online; 2024 May; 26(1):13. PubMed ID: 38750435
[TBL] [Abstract][Full Text] [Related]
19. Hemicolectomy with concomitant heated intraperitoneal chemotherapy: a case study.
Edwards JP; Rodenberg B; Niles SD; Ploessl J
J Extra Corpor Technol; 2005 Mar; 37(1):75-8. PubMed ID: 15804163
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors for major post-operative complications following intraperitoneal hyperthermic perfusion for pseudomyxoma peritonei: A retrospective cohort study.
Zhang X; Gao SC
J Minim Access Surg; 2024 Mar; ():. PubMed ID: 38557560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
